Key facts
- This page summarizes Joshua Rosen's Form 4 filing for Vireo Growth Inc. (VREOF).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Oct 2024, 16:26.
Joshua Rosen - 23 Aug 2024 Form 4 Insider Report for Vireo Growth Inc. (VREOF)
- Reporting relationship
- CEO and Interim CFO, Director
- Issuer ticker
- VREOF
- Reported as of
- 23 Aug 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Oct 2024, 16:26:40 UTC
- Prior SEC filing
- 04 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amber Shimpa, Attorney-in-Fact for Joshua Rosen
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joshua Rosen filed Form 4 for Vireo Growth Inc. (VREOF) on 11 Oct 2024.
Change
- Previous filing in this sequence was filed on 04 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VREOF
transaction
Subordinate Voting Shares
Award
- Transaction value
- $0
- Shares
- +500,000
- Change %
- Price
- $0.000000
- Shares after
- 500,000
- Date
- 10 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
VREOF
holding
Subordinate Voting Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 730,014
- Date
- 23 Aug 2024
- Ownership
- By Bengal Catalyst Fund LP
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VREOF
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +250,000
- Change %
- Price
- $0.000000
- Shares after
- 250,000
- Date
- 23 Aug 2024
- Ownership
- Direct
- Underlying class
- Subordinate Voting Shares
- Underlying amount
- 250,000
- Exercise price
- $0.4700
- Footnotes
- F3
VREOF
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +500,000
- Change %
- Price
- $0.000000
- Shares after
- 500,000
- Date
- 09 Oct 2024
- Ownership
- Direct
- Underlying class
- Subordinate Voting Shares
- Underlying amount
- 500,000
- Exercise price
- $0.5000
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Joshua Rosen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Represents subordinate voting shares underlying restricted stock units ("RSUs") granted to Mr. Rosen in connection with his Separation Agreement with the Company. The RSUs are granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, and vest in 12 equal installments commencing January 1, 2025 and ending on December 1, 2025.
Footnote F2
Shares owned by Bengal Catalyst Fund LP. As Managing Partner of Bengal Capital, Mr. Rosen has shared voting control over these shares.
Footnote F3
Vests in tranches of 62,500 options upon the first, second, third and fourth anniversary dates following the grant date.